Physician profile
Paul Levy
NPI 1346225943
$645.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.49 · 2021: $16.49 · 2022: $171 · 2023: $146 · 2024: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.06 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $146.16 | 2024 | Terlivaz |
| Janssen Biotech, INC. | $138.39 | 2019-2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $55.17 | 2023-2024 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.89 | 2019 | |
| Phathom Pharmaceuticals, INC. | $24.33 | 2024 | Voquezna |
| Celgene Corporation | $24.17 | 2022 | |
| Merck Sharp & Dohme LLC | $22.77 | 2024 | Dificid |
| Pfizer INC. | $19.79 | 2024 | |
| Organon LLC | $18.00 | 2023 | Hadlima, Renflexis |
| Qol Medical, LLC | $16.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.